Final deadline imminent: the schall law firm encourages investors in y-mabs therapeutics, inc. with losses of $100,000 to contact the firm

Los angeles, ca / accesswire / march 15, 2023 / the schall law firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against y-mabs therapeutics, inc. ("y-mabs" or "the company") (nasdaq:ymab) for violations of 10(b) and 20(a) of the securities exchange act of 1934 and rule 10b-5 promulgated thereunder by the u.s. securities and exchange commission. investors who purchased the company's securities between october 6, 2020 and october 28, 2022, inclusive (the ''class period''), are encouraged to contact the firm before march 20, 2023.
YMAB Ratings Summary
YMAB Quant Ranking